TNF and Alzheimer disease: While clinical symptomologies of AD typically appear later in life, there is a long preclinical phase which includes molecular dysregulation—e.g., elevations of neuroinflammatory factors such as tumor necrosis factor alpha (TNFα)—which contributes to pathogenesis [14].